Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.7%

1 terminated out of 37 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

89% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (14)
P 1 (3)
P 2 (3)
P 4 (1)

Trial Status

Recruiting17
Completed8
Not Yet Recruiting6
Active Not Recruiting2
Enrolling By Invitation1
Terminated1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT07557342Recruiting

Assessment of Sexual Well-being in Patients With Gynecologic Cancer and Their Partners: the ONCOSEX Study

NCT06904339Not ApplicableRecruitingPrimary

Communication About Sexual Health in Gynecologic Cancer

NCT07327125Not ApplicableRecruitingPrimary

Effect of Skin Closure Techniques on Body Image in Women Undergoing Gynecologic Surgery

NCT07024784Phase 2RecruitingPrimary

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

NCT07497802Not ApplicableNot Yet RecruitingPrimary

Mindfulness-Based Psychoeducation for Women With Gynecological Cancer

NCT07483905Not Yet RecruitingPrimary

Interest in Nighttime Day Hospital Chemotherapy Infusions Among Gynecologic Cancer Patients

NCT07038369Phase 1Active Not Recruiting

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

NCT07121738Not ApplicableRecruitingPrimary

A Prospective Study of a Lifestyle Medicine Survivorship Program for Patients With Gynecologic Cancer

NCT07406789Phase 2Not Yet RecruitingPrimary

Phase II, Prospective, Randomized, Proof-of-concept Study to Evaluate the Effects of a Personalized Dietary Intervention in Women With Advanced Gynecologic or Breast Tumors Treated With Antibody-Drug Conjugates (ADCs).

NCT07217262Not ApplicableRecruiting

Proactive Costs of Care Study

NCT07393633CompletedPrimary

Assessing Whole-body Metabolism in Gynecologic Cancers in Response to a Single Chemotherapy Cycle and/ or Immunotherapy

NCT07055854Phase 1RecruitingPrimary

Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors

NCT07290972Recruiting

Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India

NCT07313839Not ApplicableRecruitingPrimary

Comparison of Self-Locking Versus Traditional Sutures in Double-Layer Laparoscopic Vaginal Vault Closure After Hysterectomy (BI-SURE Trial)

NCT07312825CompletedPrimary

Effectiveness of Combined Fascial Plane Blocks for Postoperative Pain in Gynecologic Oncology Surgery

NCT07216456Not ApplicableNot Yet Recruiting

Vaginal Dilator Therapy After Pelvic Radiation

NCT06619769Not ApplicableRecruitingPrimary

eSense-Cancer: Adapting an Online Intervention for Sexual Health Concerns to Gynecologic Cancer

NCT07039526Phase 2Recruiting

Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.

NCT06731998Not ApplicableRecruiting

Optimal Perioperative Pain Control in Minimally Invasive Abdominal Cancer Surgery

NCT07105553Not ApplicableCompleted

Glove Compression for Chemotherapy-Induced Neuropathy

Scroll to load more

Research Network

Activity Timeline